Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
Completed
Conditions studied: Radiation Therapy, Cancer, Cancer of Anus, Cancer of Bladder, Cancer of Cervix, Cancer of Colon, Cancer of Rectum, Cancer of Esophagus, Cancer of Gallbladder, Cancer of Liver, Cancer of Ovary, Cancer of Pancreas, Cancer of Prostate, Cancer of Kidney and Renal Pelvis, Cancer of Stomach, Cancer of Testis, Cancer of Uterus, Cancer of Uterus and Cervix, Cancer of Kidney
In brief
Collect blood samples and associated clinical data prior to, during, and post radiation treatment.
Key facts
- Study ID
- NCT03133286
- Run by
- DxTerity Diagnostics
- People needed
- 16
- Starts
- 2017-04-06
- Expected to finish
- 2020-02-25
- Last updated by the study team
- 2024-08-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male and female patients age 18 or older
- Have a permanent address in the United States for the duration of the study
- Diagnosed with a primary gastrointestinal (GI), genitourinary (GU), or gynecological (GYN) cancer
- Planned radiation therapy to the abdominal/pelvic area as part of clinical care
- Able to provide informed consent
You may not qualify if…
- Receipt of radiation within three (3) months to abdominal/pelvic area prior to scheduled start of Radiation Treatment
Where it is running
- DxTerity Diagnostics — Compton, California, United States
- 21st Century Oncology — Bradenton, Florida, United States
- 21st Century Oncology — Fort Myers, Florida, United States
- 21st Century Oncology — Plantation, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.